Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 2.0x - 2.3x | 2.1x |
| Selected Fwd Ps Multiple | 2.0x - 2.3x | 2.1x |
| Fair Value | C$0.46 - C$0.51 | C$0.49 |
| Upside | 51.9% - 67.8% | 59.9% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Humble Grow Co. | - | OTCPK:DLTN.F |
| SNDL Inc. | - | NasdaqCM:SNDL |
| Aequus Pharmaceuticals Inc. | - | TSXV:AQS |
| Grey Wolf Animal Health Corp. | - | TSXV:WOLF |
| Numinus Wellness Inc. | - | TSX:NUMI |
| Avicanna Inc. | - | TSX:AVCN |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| DLTN.F | SNDL | AQS | WOLF | NUMI | AVCN | |||
| OTCPK:DLTN.F | NasdaqCM:SNDL | TSXV:AQS | TSXV:WOLF | TSX:NUMI | TSX:AVCN | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 56.5% | 70.7% | -29.0% | NM- | 52.5% | 169.6% | ||
| 3Y CAGR | 10.9% | 154.1% | -53.8% | 49.0% | 197.4% | 120.3% | ||
| Latest Twelve Months | 4.4% | 1.3% | -29.6% | 6.1% | 19.3% | 109.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -13.2% | -224.3% | -334.6% | 1.8% | -1221.9% | -1592.8% | ||
| Prior Fiscal Year | -43.0% | -18.5% | -232.7% | 11.2% | -691.1% | -364.0% | ||
| Latest Fiscal Year | -24.6% | -10.3% | -1163.1% | 2.4% | -130.5% | -52.1% | ||
| Latest Twelve Months | -27.7% | -10.3% | -647.6% | 3.5% | -113.5% | -27.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -7.6x | -1.3x | -2.9x | 11.2x | -1.0x | -7.1x | ||
| Price / LTM Sales | 0.1x | 0.6x | 1.6x | 1.3x | 0.7x | 1.4x | ||
| LTM P/E Ratio | -0.2x | -5.6x | -0.2x | 38.2x | -0.6x | -5.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.1x | 0.7x | 1.6x | |||||
| Historical LTM P/S Ratio | 2.7x | 20.2x | 812.7x | |||||
| Selected Price / Sales Multiple | 2.0x | 2.1x | 2.3x | |||||
| (x) LTM Sales | 25 | 25 | 25 | |||||
| (=) Equity Value | 51 | 53 | 56 | |||||
| (/) Shares Outstanding | 110.2 | 110.2 | 110.2 | |||||
| Implied Value Range | 0.46 | 0.48 | 0.51 | |||||
| FX Rate: CAD/CAD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.46 | 0.48 | 0.51 | 0.31 | ||||
| Upside / (Downside) | 50.9% | 58.8% | 66.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DLTN.F | SNDL | AQS | WOLF | NUMI | AVCN | |
| Value of Common Equity | 4 | 519 | 1 | 35 | 16 | 34 | |
| (/) Shares Outstanding | 365.3 | 257.3 | 132.6 | 34.2 | 322.3 | 110.2 | |
| Implied Stock Price | 0.01 | 2.02 | 0.01 | 1.03 | 0.05 | 0.31 | |
| FX Conversion Rate to Trading Currency | 1.43 | 1.43 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.01 | 1.41 | 0.01 | 1.03 | 0.05 | 0.31 | |
| Trading Currency | USD | USD | CAD | CAD | CAD | CAD | |
| FX Rate to Reporting Currency | 1.43 | 1.43 | 1.00 | 1.00 | 1.00 | 1.00 | |